Publicaciones (63) Publicaciones de MÓNICA MARTÍNEZ CENGOTITABENGOA

2024

  1. De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease

    BMJ Open, Vol. 14, Núm. 4

  2. Nuevas prescripciones de antidepresivos antes, durante y tras la pandemia de Covid 19

    Jornada de Atención Primaria de Osakidetza (1ª. San Sebastián. 2024)

2023

  1. Efecto de la pandemia en la prescripción de tratamientos para las adicciones

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  2. Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder

    International Journal of Bipolar Disorders, Vol. 11, Núm. 1

  3. Global intellectual ability and adaptive functioning in children with FASD with and without sentinel facial features

    American Journal of Drug and Alcohol Abuse, Vol. 49, Núm. 1, pp. 123-128

2022

  1. Association between polarity of first episode and solar insolation in bipolar I disorder

    Journal of Psychosomatic Research, Vol. 160

  2. Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition

    World Journal of Biological Psychiatry, Vol. 23, Núm. 4, pp. 307-317

  3. Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review

    European Neuropsychopharmacology, Vol. 54, pp. 90-99

  4. Remote video interface psychological assessment during the COVID-19 pandemic: Experiences of consultants and clients

    Journal of Investigative Psychology and Offender Profiling, Vol. 19, Núm. 2, pp. 88-99

2021

  1. Corrigendum to “Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121–136]” (European Neuropsychopharmacology (2020) 36 (121–136), (S0924977X20301802), (10.1016/j.euroneuro.2020.05.006))

    European Neuropsychopharmacology

  2. DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis – A narrative review from the ECNP bipolar disorders network

    European Neuropsychopharmacology, Vol. 47, pp. 54-61

  3. Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder

    International Journal of Bipolar Disorders, Vol. 9, Núm. 1

2020

  1. Alterations of the HPA Axis Observed in Patients with Major Depressive Disorder and Their Relation to Early Life Stress: A Systematic Review

    Neuropsychobiology, Vol. 79, Núm. 6, pp. 417-427

  2. Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action

    European Neuropsychopharmacology, Vol. 36, pp. 121-136

2019

  1. Association between medication adherence and oxidative stress in patients with first-episode mania

    Frontiers in Psychiatry, Vol. 10, Núm. MAR

  2. Association between solar insolation and a history of suicide attempts in bipolar I disorder

    Journal of Psychiatric Research, Vol. 113, pp. 1-9

  3. Efectividad de las medidas de atención farmacéutica para la deprescripción de benzodiazepinas y análogos en atención primaria

    Congreso Nacional de Atención Farmacéutica (11º. Cádiz. 2019)

  4. Influencia del sexo en el tratamiento con olanzapina: una revisión sistemática

    Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica, Vol. 26, Núm. 2, pp. 45-51

2018

  1. Benzodiazepine prescriptions and falls in older men and women

    Revista de Psiquiatria y Salud Mental, Vol. 11, Núm. 1, pp. 19-26

  2. Can lithium salts prevent depressive episodes in the real world?

    European Neuropsychopharmacology, Vol. 28, Núm. 12, pp. 1351-1359